| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K71781559 |
| PharmacoGx | BRD-K71781559 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZNF331 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | ALPL | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | RGS3 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | MAP3K2 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | GPR75-ASB3 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | SEC14L3 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | ERICH1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | PPP5C | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | IGF2R | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | CH17-270A2.2 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |
